These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20042308)

  • 1. Development and validation of a LC-MS/MS method for determination of bivalirudin in human plasma: Application to a clinical pharmacokinetic study.
    Pan G; Wang X; Huang Y; Gao X; Wang Y
    J Pharm Biomed Anal; 2010 May; 52(1):105-9. PubMed ID: 20042308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a highly sensitive LC-MS/MS method for quantitation of bivalirudin in human plasma: application to a human pharmacokinetic study.
    Chai D; Wang R; Bai N; Cai Y; Liang B
    Biomed Chromatogr; 2013 Dec; 27(12):1788-93. PubMed ID: 23893840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of bivalirudin, a novel anticoagulant peptide, in human plasma by LC-MS/MS: Method development, validation and application to pharmacokinetics.
    Li XJ; Sun YT; Yin L; Zhang XJ; Yang Y; Paul Fawcett J; Cui YM; Gu JK
    J Pharm Anal; 2013 Feb; 3(1):1-8. PubMed ID: 29403790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric catheterization laboratory anticoagulation with bivalirudin.
    Forbes TJ; Hijazi ZM; Young G; Ringewald JM; Aquino PM; Vincent RN; Qureshi AM; Rome JJ; Rhodes JF; Jones TK; Moskowitz WB; Holzer RJ; Zamora R
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):671-9. PubMed ID: 21433272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of clevidipine and its primary metabolite in dog plasma by liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic study.
    Zhou Y; Li H; He X; Jia M; Ni Y; Xu M; Chen H; Li W
    J Pharm Biomed Anal; 2014 Nov; 100():294-299. PubMed ID: 25194342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of bentysrepinine (Y101) and its metabolites M8 and M9 in human plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
    Liu X; Huang C; Xue L; Xu Q; Xia W; Li X; Miao L
    J Pharm Biomed Anal; 2018 Feb; 150():287-293. PubMed ID: 29258048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with anticoagulation with bivalirudin during extracorporeal membrane oxygenation].
    Van Sint Jan N; Díaz R; Fajardo C; Agliatti R; Palavecino M; Hasbún P; Regueira T
    Rev Med Chil; 2017 Jun; 145(6):710-715. PubMed ID: 29171618
    [No Abstract]   [Full Text] [Related]  

  • 8. Liquid chromatography-tandem mass spectrometry of recombinant human extracellular superoxide dismutase (rhSOD3) in mouse plasma and its application to pharmacokinetic study.
    Jeong JW; Oh JH; Ji YG; Shin YM; Lee MH; Kang NS; Lee W; Kim SS; Kim TY; Koo TS
    J Pharm Biomed Anal; 2019 Feb; 164():590-597. PubMed ID: 30469108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics and pharmacodynamics of bivalirudin in young healthy Chinese volunteers.
    Zhang DM; Wang K; Zhao X; Li YF; Zheng QS; Wang ZN; Cui YM
    Acta Pharmacol Sin; 2012 Nov; 33(11):1387-94. PubMed ID: 22659624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination of ketoconazole by UPLC-MS/MS in human plasma and its application to pharmacokinetic study.
    Hu ML; Xu M; Ye Q
    Drug Res (Stuttg); 2014 Oct; 64(10):548-52. PubMed ID: 24452517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of phentermine and topiramate in human plasma by liquid chromatography-tandem mass spectrometry with positive/negative ion-switching electrospray ionization and its application in pharmacokinetic study.
    Ni Y; Zhou Y; Xu M; He X; Li H; Haseeb S; Chen H; Li W
    J Pharm Biomed Anal; 2015 Mar; 107():444-9. PubMed ID: 25668796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of Sodium Tanshinone IIA Sulfonate in human plasma by LC-MS/MS and its application to a clinical pharmacokinetic study.
    Qin W; Wang B; Lu X; Liu H; Wang L; Qi W
    J Pharm Biomed Anal; 2016 Mar; 121():204-208. PubMed ID: 26812478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development, validation, and clinical pharmacokinetic application of ultra-performance liquid chromatography/tandem mass spectrometry method for simultaneously determining a novel recombinant hirudin derivative (Neorudin) and its active metabolite in human serum.
    Dong X; Meng Z; Jin J; Gu R; Dou G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1063():204-213. PubMed ID: 28886579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of endostar in rat plasma by LC-MS/MS and its application in a pharmacokinetic study.
    Li YC; Liang Y; Tang ZY; Xiao YN; Hao HP; Wang GJ
    J Pharm Biomed Anal; 2012 Nov; 70():505-11. PubMed ID: 22858310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sensitive LC-MS/MS method for analysis of pericyazine in presence of 7-hydroxypericyazine and pericyazine sulphoxide in human plasma and its application to a comparative bioequivalence study in Chinese healthy volunteers.
    Cai HL; Deng Y; Fang PF; Cao S; Hou ZY; Wu YQ; Chen XJ; Yan M; Zhang B
    J Pharm Biomed Anal; 2017 Feb; 135():67-74. PubMed ID: 28012307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a liquid chromatography-electrospray ionization-tandem mass spectrometry method for the determination of urolithin C in rat plasma and its application to a pharmacokinetic study.
    Bayle M; Roques C; Marion B; Audran M; Oiry C; Bressolle-Gomeni FMM; Cros G
    J Pharm Biomed Anal; 2016 Nov; 131():33-39. PubMed ID: 27521987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a sensitive LC-MS/MS assay for the simultaneous quantification of allitinib and its two metabolites in human plasma.
    Lin L; Gao Z; Chen X; Zhong D
    J Pharm Biomed Anal; 2013 Dec; 86():49-55. PubMed ID: 23973791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bivalirudin: a direct thrombin inhibitor in percutaneous coronary interventions].
    Hansen PR
    Ugeskr Laeger; 2006 Sep; 168(38):3207-9. PubMed ID: 17026893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical pharmacokinetic evaluation of a new formulation of a bifendate solid dispersion using a supercritical fluid chromatography-tandem mass spectrometry method.
    Liu M; Zhao L; Yang D; Ma J; Wang X; Zhang T
    J Pharm Biomed Anal; 2014 Nov; 100():387-392. PubMed ID: 25221916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.